MRNA Moderna, Inc. Stock Quote

MRNA [NASD]

Index	S&P 500	P/E	4.22	EPS (ttm)	34.01	Insider Own	5.20%	Shs Outstand	402.00M	Perf Week	10.15%
Market Cap	53.83B	Forward P/E	16.47	EPS next Y	8.70	Insider Trans	-6.23%	Shs Float	360.23M	Perf Month	-4.49%
Income	14.64B	PEG	0.25	EPS next Q	4.75	Inst Own	64.10%	Short Float	4.28%	Perf Quarter	-2.04%
Sales	22.60B	P/S	2.38	EPS this Y	1423.00%	Inst Trans	1.09%	Short Ratio	2.15	Perf Half Y	-40.81%
Book/sh	42.48	P/B	3.38	EPS next Y	-68.64%	ROA	65.50%	Target Price	230.27	Perf Year	-13.61%
Cash/sh	26.94	P/C	5.32	EPS next 5Y	16.80%	ROE	121.90%	52W Range	119.01 - 497.49	Perf YTD	-43.55%
Dividend	-	P/FCF	4.13	EPS past 5Y	111.10%	ROI	81.90%	52W High	-72.18%	Beta	1.70
Dividend %	-	Quick Ratio	1.60	Sales past 5Y	179.40%	Gross Margin	84.80%	52W Low	16.28%	ATR	10.70
Employees	2700	Current Ratio	1.80	Sales Q/Q	213.20%	Oper. Margin	71.90%	RSI (14)	46.62	Volatility	6.02% 8.00%
Optionable	Yes	Debt/Eq	0.05	EPS Q/Q	202.30%	Profit Margin	64.80%	Rel Volume	0.99	Prev Close	143.38
Shortable	Yes	LT Debt/Eq	0.04	Earnings	May 04 BMO	Payout	0.00%	Avg Volume	7.18M	Price	138.39
Recom	2.60	SMA20	-0.98%	SMA50	-10.34%	SMA200	-45.36%	Volume	1,699,149	Change	-3.48%

Feb-01-22

Upgrade

Redburn

Sell → Neutral

Jan-26-22

Upgrade

Deutsche Bank

Sell → Hold

$175

Jan-21-22

Upgrade

BofA Securities

Underperform → Neutral

$135 → $180

Jan-21-22

Initiated

UBS

Neutral

$221

Dec-07-21

Initiated

Cowen

Market Perform

Nov-09-21

Initiated

Wolfe Research

Outperform

$304

Oct-22-21

Initiated

Deutsche Bank

Sell

$250

Oct-15-21

Upgrade

Piper Sandler

Neutral → Overweight

$445

Aug-06-21

Downgrade

Piper Sandler

Overweight → Neutral

$246 → $445

Aug-06-21

Downgrade

Oppenheimer

Outperform → Perform

Jul-15-21

Reiterated

Jefferies

Hold

$170 → $250

Feb-01-21

Downgrade

BofA Securities

Neutral → Underperform

Dec-16-20

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$150

Dec-16-20

Downgrade

Jefferies

Buy → Hold

$90 → $150

Dec-09-20

Downgrade

Needham

Buy → Hold

Nov-23-20

Initiated

Wells Fargo

Equal Weight

$92

Nov-17-20

Downgrade

BMO Capital Markets

Outperform → Market Perform

$109

Sep-08-20

Downgrade

SVB Leerink

Mkt Perform → Underperform

$58 → $41

Jul-23-20

Initiated

SVB Leerink

Mkt Perform

Jul-20-20

Downgrade

JP Morgan

Overweight → Neutral

$89

May-20-22 06:00AM	Here's How Moderna Could Top $450 Again Motley Fool
May-19-22 03:32PM	10 Market-Moving Stocks to Watch Today Insider Monkey
02:16PM	It's been a rocky two years for Mass. public companies. Here are some winners and losers. American City Business Journals
10:53AM	FDA to act quickly on Moderna's COVID vaccine bid for youngest kids -Califf Reuters
May-18-22 03:55PM	Moderna to Present at the UBS 2022 Global Healthcare Conference ACCESSWIRE
02:05PM	Dentsply Sirona could face NASDAQ delisting for failing to file financial report during investigation American City Business Journals
11:53AM	Why Pfizer Looks Better Than Moderna as a Long-Term Buy Motley Fool
11:07AM	2 Top Healthcare Stocks to Buy for the Long Haul Motley Fool
10:10AM	Moderna (MRNA) Stock Rises 4%: What's Behind the Upside? Zacks
10:07AM	Pfizer (PFE) Gets EUA for Use of Comirnaty Booster in Children Zacks
09:06AM	Vertex (VRTX) Outperforms Industry This Year So Far: Here's Why Zacks
08:38AM	Moderna Just Made a $700,000 Mistake Motley Fool
07:52AM	Moderna's Chairman Defends Executive Hiring Process After Firing New CFO In Just One Day Benzinga
07:00AM	IAVI and Moderna Launch First-in-Africa Clinical Trial of mRNA HIV Vaccine Development Program ACCESSWIRE
12:00AM	Moderna chair defends executive hiring process after CFO fiasco Financial Times
May-17-22 04:01PM	Pfizer Retakes A Key Line And Drags BioNTech, Moderna With It Investor's Business Daily
10:55AM	Pfizer, BioNTech Rise After FDA Approves Covid Boosters for Children Investing.com
07:00AM	Moderna Announces Advancements in mRNA Platform Science for Application Across Multiple Diseases at Science and Technology Day ACCESSWIRE
May-16-22 04:35PM	Is Moderna Stock A Buy On Its Big First-Quarter Covid Vaccine Number? Investor's Business Daily
06:45AM	7 Undervalued Blue-Chip Stocks to Buy Now InvestorPlace
06:41AM	Moderna and former Dentsply Sirona CFO sign 'claw back' agreement on $700K severance American City Business Journals
May-14-22 06:00AM	Moderna CFOs departure reignites debate over companys culture Financial Times
May-13-22 05:00PM	Moderna Acted Fast to Remove CFO After Hearing of Probe Bloomberg +5.95%
03:47PM	British drug makers honoured at Prix Galien UK Awards The Telegraph
11:45AM	2 Stocks With 75% to 183% Upside, According to Wall Street Motley Fool
11:07AM	2 Problems and (Maybe) 1 Opportunity for Moderna This Summer Motley Fool
10:05AM	Moderna Stock Will Come Back Stronger After CFO Exit InvestorPlace
May-12-22 05:17PM	Dentsply Sirona is no stranger to losing a CEO over securities violations American City Business Journals +5.46%
03:15PM	Dozens Of Major Stocks Crash More Than 70% In Epic Dive Investor's Business Daily
11:57AM	Moderna Concludes FDA Submission For Its COVID-19 Shot In Adolescents, Kids Benzinga
10:43AM	SoftBank vision fund posts $27B loss, Moderna CFO ousted, Abbott could restart baby formula production Yahoo Finance Video
08:34AM	Company News for May 12, 2022 Zacks
May-11-22 03:50PM	Moderna completes FDA submission for use of COVID shot in adolescents, kids Reuters -6.72%
03:48PM	Beyond Meat stock slumps, Nike claims StockX is selling fake shoes, Moderna CFO steps down Yahoo Finance Video
03:42PM	Why Did Moderna CFO Exit Just A Day After Taking Charge Benzinga
01:49PM	Moderna Ousts Finance Chief Jorge Gomez in First Week on the Job The Wall Street Journal
01:06PM	Moderna parts ways with CFO after his former employer, Dentsply Sirona, discloses investigation American City Business Journals
12:48PM	Healthcare boss earns $700,000 in one day after abruptly quitting The Telegraph
10:22AM	Moderna fires new CFO after one day American City Business Journals
09:21AM	Modernas New CFO Is Leaving After Former Employer Discloses Internal Investigation Barrons.com
08:43AM	Moderna CFO out after two days in the role as former employer Dentsply discloses probe of financial reporting MarketWatch
08:24AM	Moderna CFO exits a day after taking charge as former employer launches probe Reuters
08:22AM	UPDATE 2-Moderna CFO leaves within a day as former employer launches probe Reuters
08:15AM	Moderna's recently appointed CFO is out after former employer Dentsply discloses internal probe of financial reporting MarketWatch
08:00AM	Departure of Jorge Gomez and Continuation of David Meline as Chief Financial Officer ACCESSWIRE
07:30AM	Is Moderna Wasting a Golden Opportunity? Motley Fool
06:30AM	This 1 Thing Could Make Novavax a Vaccine Leader Motley Fool
May-10-22 02:47PM	Novavax (NVAX) Down on Q1 Earnings and Sales Lagging Estimates Zacks
May-09-22 01:51PM	A Plan to Fix Vaccine Inequity Offers False Comfort Barrons.com
08:16AM	Moderna Files Motion To Dismiss COVID-19 Vaccine Related Patent Claims: WSJ Benzinga
07:00AM	Moderna to Host Annual Science and Technology Day on May 17, 2022 ACCESSWIRE
06:00AM	COVID vaccine makers shift focus to boosters Reuters
May-08-22 08:30AM	3 Growth Stocks That Are Screaming Buys in May Motley Fool
06:00AM	4 Bold Words From Moderna's CEO That Could Be Worth Billions Motley Fool
May-07-22 07:57AM	Why GSK May Have Bet Too Big on a Pandemic Pipeline Motley Fool
May-06-22 05:07PM	Pharma and Rideshare Earnings Roundup InvestorPlace -5.37%
02:45PM	10 Best Stocks to Buy According to Billionaire Jeffrey Talpins Insider Monkey
06:56AM	Coronavirus tally: FDA limits who can get J&J COVID vaccine over rare blood clot issue MarketWatch
06:39AM	FDA limits use of J&J COVID-19 vaccine over blood clot concerns Yahoo Finance
06:00AM	2 Reasons Moderna Could Dominate the Long-Term Vaccine Market Motley Fool
05:55AM	Why Moderna Might Make Less Money This Year Than Everyone Expects Motley Fool
May-05-22 04:53PM	These 13 Nasdaq-100 stocks had the biggest swings up and down after the Fed raised rates. Should you be scared off? MarketWatch -8.40%
10:04AM	UPDATE 1-EU regulator hopes to approve COVID variant-adapted vaccines by autumn Reuters
07:36AM	Pfizer is looking beyond the COVID-19 market, aiming to be the partner of choice for biotech MarketWatch
06:46AM	Powells Balancing Act With the Punch Bowl Is Working Beautifully. For Now. Barrons.com
06:00AM	This Prediction From Moderna's CEO Should Eliminate Investors' Biggest Worry Motley Fool
May-04-22 05:08PM	Why Moderna Stock Jumped Today Motley Fool +5.81%
04:39PM	Vaccine Makers Slump as Moderna, Pfizer Leave Full-Year Guidance Intact Bloomberg
04:11PM	Why Moderna's Outlook Doesn't Inspire Hope For Covid Vaccine Sales Investor's Business Daily
03:56PM	Moderna CEO Says FDA Meeting Will Be Too Late to Switch Covid Strains for Fall Vaccine Barrons.com
03:25PM	Stocks Rally as Powell Quells Fear of Bigger Hikes: Markets Wrap Bloomberg
02:26PM	After soaring Covid-19 vaccine sales, Moderna lays out future plans American City Business Journals
01:33PM	Stock Market Gains Ahead Of Fed Announcement; Oil And Utilities Sectors Shine Investor's Business Daily
12:29PM	Moderna prepares to sell COVID-19 vaccine privately as US delays booster call Yahoo Finance
12:26PM	Stock Market Falls Ahead Of Fed Announcement, Mixed Earnings, Slowing Service Sector Investor's Business Daily
12:02PM	Moderna targets autumn release for Omicron vaccine Financial Times
11:42AM	Moderna stock dips despite blowout quarterly earnings Yahoo Finance Video
11:39AM	Moderna (MRNA) Beats on Q1 Earnings, to Start Two Late Studies Zacks
11:02AM	This Number in Moderna's Q1 Results Is a Game-Changer Motley Fool
10:52AM	Moderna Stock Active After Smashing Q1 Earnings Forecast, Affirming Vaccine Sales Forecast TheStreet.com
10:41AM	Several people who attended weekend White House correspondents dinner have since tested positive for COVID MarketWatch
10:11AM	Moderna CEO talks huge earnings beat, COVID-19 vaccine sales, new boosters Yahoo Finance Video
09:48AM	Lyft stock tumbles, dragging down Uber stock with it Yahoo Finance Video
09:12AM	Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names Zacks
08:56AM	Moderna Earnings: What Happened with MRNA Investopedia
08:25AM	Moderna (MRNA) Q1 Earnings and Revenues Top Estimates Zacks
07:48AM	Markets are primed for how Powell will respond to this key question on interest rates MarketWatch
07:33AM	Moderna's stock soars 8% after beating revenue, earnings expectations for the quarter MarketWatch
07:09AM	Moderna Stock Jumps After Earnings Trounce Estimates Barrons.com
07:04AM	Moderna sees higher COVID vaccine sales later this year Reuters
07:02AM	UPDATE 2-Moderna sees higher COVID vaccine sales in second half of 2022 Reuters
06:52AM	Moderna Reports First Quarter 2022 Financial Results and Provides Business Updates ACCESSWIRE
03:45AM	Lyft, Match Group, Yum! Brands Fall Premarket; Starbucks, AMD, Airbnb Rise Investing.com
May-03-22 12:08PM	Moderna Earnings: What to Look For From MRNA Investopedia
May-02-22 04:24PM	Why Moderna Shares Rallied Nearly 6% on Monday Motley Fool +5.71%
03:44PM	10 Market-Moving Stocks to Watch on Monday Insider Monkey
03:21PM	Earnings: AMD, Lyft, Moderna among companies set to report quarterly results this week Yahoo Finance Video
01:22PM	Moderna Bullish On COVID-19 Vaccine For Younger Kids To Be Ready Next Month: Reuters Benzinga
10:26AM	Is a Beat Likely for Moderna (MRNA) This Earnings Season? Zacks
09:48AM	Pfizer COVID-19 pill fails as preventive therapy in trial Yahoo Finance Video

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, Metagenomi, Inc., and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd.; Catalent Inc., Laboratorios Farmaceuticos Rovi, S.A., Recipharm, and Lonza Group; Aldevron, LLC; Institute for Life Changing Medicines; and AbCellera Biologics Inc. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoge Stephen	President	May 13	Option Exercise	4.29	15,000	64,400	1,637,820	May 16 04:09 PM
AFEYAN NOUBAR	Director	May 13	Sale	134.47	100,000	13,446,611	5,816,657	May 13 07:30 PM
Hoge Stephen	President	May 13	Sale	132.69	15,000	1,990,350	1,622,820	May 16 04:09 PM
Hoge Stephen	President	May 12	Option Exercise	10.90	5,000	54,500	1,627,820	May 16 04:09 PM
Bancel Stephane	Chief Executive Officer	May 12	Sale	121.10	10,000	1,211,000	6,894,880	May 13 04:42 PM
AFEYAN NOUBAR	Director	May 12	Sale	130.51	200,000	26,101,175	5,916,657	May 13 07:30 PM
Hoge Stephen	President	May 12	Sale	121.10	5,000	605,500	1,622,820	May 16 04:09 PM
Bancel Stephane	Chief Executive Officer	May 11	Sale	127.13	9,000	1,144,164	5,395,535	May 13 04:42 PM
AFEYAN NOUBAR	Director	May 11	Sale	130.74	10,000	1,307,400	2,229,673	May 13 07:30 PM
Nader Francois	Director	May 10	Option Exercise	18.87	23,100	435,897	23,803	May 12 04:22 PM
Andres Juan	See remarks	May 10	Sale	133.71	195	26,074	9,309	May 11 04:24 PM
Meline David W	Chief Financial Officer	May 10	Sale	133.71	156	20,859	2,583	May 11 04:26 PM
Hoge Stephen	President	May 10	Sale	133.71	234	31,289	1,622,820	May 11 04:29 PM
Nader Francois	Director	May 10	Sale	136.10	3,196	434,976	20,607	May 12 04:22 PM
Andres Juan	See remarks	May 09	Option Exercise	134.40	435	58,464	9,504	May 11 04:24 PM
Meline David W	Chief Financial Officer	May 09	Option Exercise	134.40	348	46,771	2,739	May 11 04:26 PM
Hoge Stephen	President	May 09	Option Exercise	134.40	522	70,157	1,623,054	May 11 04:29 PM
Bancel Stephane	Chief Executive Officer	May 05	Sale	151.87	10,000	1,518,700	6,904,880	May 06 04:09 PM
Andres Juan	See remarks	May 04	Option Exercise	14.22	2,000	28,440	11,069	May 06 04:06 PM
Andres Juan	See remarks	May 04	Sale	153.23	2,000	306,460	9,069	May 06 04:06 PM
Bancel Stephane	Chief Executive Officer	May 04	Sale	147.25	9,000	1,325,272	5,408,535	May 06 04:09 PM
Hoge Stephen	President	May 03	Option Exercise	0.99	10,000	9,900	1,632,532	May 04 04:37 PM
Hoge Stephen	President	May 03	Sale	141.93	10,000	1,419,300	1,622,532	May 04 04:37 PM
Hoge Stephen	President	May 02	Option Exercise	0.99	10,000	9,900	1,632,532	May 04 04:37 PM
Hoge Stephen	President	May 02	Sale	134.87	10,000	1,348,700	1,622,532	May 04 04:37 PM
Andres Juan	See remarks	Apr 29	Option Exercise	14.22	2,000	28,440	11,069	May 02 04:24 PM
Andres Juan	See remarks	Apr 29	Sale	150.00	2,000	300,000	9,069	May 02 04:24 PM
AFEYAN NOUBAR	Director	Apr 28	Option Exercise	0.00	703	0	2,239,673	May 02 08:24 PM
NABEL ELIZABETH G	Director	Apr 28	Option Exercise	0.00	703	0	703	May 02 04:37 PM
Horning Sandra	Director	Apr 28	Option Exercise	0.00	703	0	703	May 02 04:38 PM
Tallett Elizabeth E	Director	Apr 28	Option Exercise	0.00	703	0	703	May 02 04:39 PM
Nader Francois	Director	Apr 28	Option Exercise	0.00	703	0	703	May 02 04:40 PM
SAGAN PAUL	Director	Apr 28	Option Exercise	0.00	703	0	703	May 02 04:42 PM
LANGER ROBERT	Director	Apr 28	Option Exercise	0.00	703	0	11,467,664	May 02 04:45 PM
Berenson Stephen	Director	Apr 28	Option Exercise	0.00	703	0	20,801	May 02 04:47 PM
Bancel Stephane	Chief Executive Officer	Apr 28	Sale	143.73	10,000	1,437,300	6,914,880	Apr 29 04:18 PM
Bancel Stephane	Chief Executive Officer	Apr 27	Sale	142.14	9,000	1,279,301	5,421,535	Apr 29 04:18 PM
Hoge Stephen	President	Apr 25	Option Exercise	5.95	20,000	118,900	1,642,532	Apr 26 04:07 PM
Hoge Stephen	President	Apr 25	Sale	143.22	20,000	2,864,497	1,622,532	Apr 26 04:07 PM
Bancel Stephane	Chief Executive Officer	Apr 21	Sale	149.43	10,000	1,494,300	6,924,880	Apr 22 04:05 PM
Andres Juan	See remarks	Apr 20	Option Exercise	14.22	2,000	28,440	11,069	Apr 22 04:08 PM
Andres Juan	See remarks	Apr 20	Sale	153.00	2,000	306,000	9,069	Apr 22 04:08 PM
Bancel Stephane	Chief Executive Officer	Apr 20	Sale	150.59	9,000	1,355,281	5,434,535	Apr 22 04:05 PM
Bancel Stephane	Chief Executive Officer	Apr 14	Sale	168.59	10,000	1,685,900	6,934,880	Apr 15 03:16 PM
Andres Juan	See remarks	Apr 13	Option Exercise	14.22	2,000	28,440	11,069	Apr 15 03:09 PM
Hoge Stephen	President	Apr 13	Option Exercise	4.29	15,000	64,400	1,637,532	Apr 14 04:06 PM
Bancel Stephane	Chief Executive Officer	Apr 13	Sale	170.26	9,000	1,532,347	5,443,535	Apr 15 03:16 PM
Andres Juan	See remarks	Apr 13	Sale	158.37	2,000	316,740	9,069	Apr 15 03:09 PM
Hoge Stephen	President	Apr 13	Sale	158.37	15,000	2,375,550	1,622,532	Apr 14 04:06 PM
Hoge Stephen	President	Apr 12	Option Exercise	10.90	5,000	54,500	1,627,532	Apr 14 04:06 PM
Hoge Stephen	President	Apr 12	Sale	159.00	5,000	795,000	1,622,532	Apr 14 04:06 PM
Bancel Stephane	Chief Executive Officer	Apr 07	Sale	153.15	10,000	1,531,500	6,944,880	Apr 08 04:03 PM
Andres Juan	See remarks	Apr 06	Option Exercise	14.22	2,000	28,440	11,069	Apr 08 04:06 PM
Andres Juan	See remarks	Apr 06	Sale	157.50	2,000	315,000	9,069	Apr 08 04:06 PM
Bancel Stephane	Chief Executive Officer	Apr 06	Sale	158.70	9,000	1,428,292	5,460,535	Apr 08 04:03 PM
Hoge Stephen	President	Apr 04	Option Exercise	0.99	20,000	19,800	1,642,532	Apr 05 04:11 PM
Hoge Stephen	President	Apr 04	Sale	177.27	20,000	3,545,400	1,622,532	Apr 05 04:11 PM
Bancel Stephane	Chief Executive Officer	Mar 31	Sale	175.22	10,000	1,752,200	6,954,880	Apr 01 04:04 PM
Andres Juan	See remarks	Mar 30	Option Exercise	14.22	2,000	28,440	11,069	Apr 01 04:06 PM
Bancel Stephane	Chief Executive Officer	Mar 30	Sale	176.83	9,000	1,591,445	5,473,535	Apr 01 04:04 PM
Andres Juan	See remarks	Mar 30	Sale	182.79	2,000	365,580	9,069	Apr 01 04:06 PM
Hoge Stephen	President	Mar 24	Option Exercise	10.90	5,000	54,500	1,627,532	Mar 25 04:09 PM
Bancel Stephane	Chief Executive Officer	Mar 24	Sale	175.52	10,000	1,755,200	6,964,880	Mar 25 04:07 PM
Hoge Stephen	President	Mar 24	Sale	175.52	5,000	877,600	1,622,532	Mar 25 04:09 PM
Andres Juan	See remarks	Mar 23	Option Exercise	14.22	2,000	28,440	11,069	Mar 25 04:13 PM
Hoge Stephen	President	Mar 23	Option Exercise	4.29	15,000	64,400	1,637,532	Mar 25 04:09 PM
Hoge Stephen	President	Mar 23	Sale	181.81	15,000	2,727,079	1,622,532	Mar 25 04:09 PM
Bancel Stephane	Chief Executive Officer	Mar 23	Sale	180.15	9,000	1,621,339	5,486,535	Mar 25 04:07 PM
Andres Juan	See remarks	Mar 23	Sale	184.66	2,000	369,320	9,069	Mar 25 04:13 PM
Hoge Stephen	President	Mar 18	Sale	171.67	7,541	1,294,533	1,622,532	Mar 21 06:07 PM
Hoge Stephen	President	Mar 17	Option Exercise	151.33	19,282	2,917,945	1,630,073	Mar 21 06:07 PM
Bancel Stephane	Chief Executive Officer	Mar 17	Sale	168.00	10,000	1,680,000	6,974,880	Mar 18 04:07 PM
Andres Juan	See remarks	Mar 16	Option Exercise	14.22	2,000	28,440	11,069	Mar 18 04:09 PM
Bancel Stephane	Chief Executive Officer	Mar 16	Sale	161.63	9,000	1,454,688	5,499,535	Mar 18 04:07 PM
Andres Juan	See remarks	Mar 16	Sale	150.01	2,000	300,020	9,069	Mar 18 04:09 PM
Andres Juan	See remarks	Mar 14	Option Exercise	14.22	2,000	28,440	11,069	Mar 15 04:19 PM
Hoge Stephen	President	Mar 14	Option Exercise	5.95	20,000	118,900	1,630,791	Mar 15 04:22 PM
Andres Juan	See remarks	Mar 14	Sale	150.00	2,000	300,000	9,069	Mar 15 04:19 PM
Hoge Stephen	President	Mar 14	Sale	140.26	20,000	2,805,200	1,610,791	Mar 15 04:22 PM
Bancel Stephane	Chief Executive Officer	Mar 10	Sale	139.54	10,000	1,395,400	6,984,880	Mar 11 04:09 PM
Bancel Stephane	Chief Executive Officer	Mar 09	Sale	132.05	9,000	1,188,450	5,512,535	Mar 11 04:09 PM
Hoge Stephen	President	Mar 03	Option Exercise	0.99	10,000	9,900	1,620,791	Mar 04 04:15 PM
Hoge Stephen	President	Mar 03	Sale	147.90	10,000	1,479,000	1,610,791	Mar 04 04:15 PM
Bancel Stephane	Chief Executive Officer	Mar 03	Sale	147.90	10,000	1,479,000	6,994,880	Mar 04 04:13 PM
Hoge Stephen	President	Mar 02	Option Exercise	0.99	10,000	9,900	1,620,791	Mar 03 04:56 PM
Andres Juan	See remarks	Mar 02	Option Exercise	14.22	2,000	28,440	11,069	Mar 03 04:53 PM
Hoge Stephen	President	Mar 02	Sale	149.44	10,000	1,494,400	1,610,791	Mar 03 04:56 PM
Bancel Stephane	Chief Executive Officer	Mar 02	Sale	149.44	9,000	1,344,960	5,525,535	Mar 03 04:49 PM
Andres Juan	See remarks	Mar 02	Sale	150.00	2,000	300,000	9,069	Mar 03 04:53 PM
Andres Juan	See remarks	Mar 01	Sale	152.53	6,365	970,822	9,069	Mar 02 04:27 PM
Andres Juan	See remarks	Feb 28	Option Exercise	0.00	14,462	0	15,434	Mar 02 04:27 PM
Andres Juan	See remarks	Feb 24	Option Exercise	14.22	2,000	28,440	2,972	Feb 25 04:35 PM
Andres Juan	See remarks	Feb 24	Sale	150.00	2,000	300,000	972	Feb 25 04:35 PM
Bancel Stephane	Chief Executive Officer	Feb 24	Sale	139.80	10,000	1,398,000	7,004,880	Feb 25 04:43 PM
Bancel Stephane	Chief Executive Officer	Feb 23	Sale	144.60	9,000	1,301,400	5,688,535	Feb 25 04:43 PM
Bancel Stephane	Chief Executive Officer	Feb 17	Sale	150.49	10,000	1,504,900	7,014,880	Feb 18 04:32 PM
Andres Juan	See remarks	Feb 16	Option Exercise	14.22	2,000	28,440	2,972	Feb 18 04:34 PM
Andres Juan	See remarks	Feb 16	Sale	150.00	2,000	300,000	972	Feb 18 04:34 PM
Bancel Stephane	Chief Executive Officer	Feb 16	Sale	147.80	9,000	1,330,200	5,701,535	Feb 18 04:32 PM
Hoge Stephen	President	Feb 14	Option Exercise	5.95	20,000	118,900	1,630,791	Feb 15 04:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience